Stockscreener 앱 받기
1.26
0.80%
0.01
전일 마감가:
$1.25
열려 있는:
$1.27
하루 거래량:
41,696
Relative Volume:
0.17
시가총액:
$3.15M
수익:
-
순이익/손실:
$-8.26M
주가수익비율:
-0.0235
EPS:
-53.609
순현금흐름:
$-12.17M
1주 성능:
-4.55%
1개월 성능:
-23.64%
6개월 성능:
-84.53%
1년 성능:
-85.46%
1일 변동 폭
$1.23
$1.28
1주일 범위
$1.22
$1.35
52주 변동 폭
$1.10
$30.43
Gri Bio Inc Stock (GRI) Company Profile
명칭
Gri Bio Inc
전화
(619) 400-1171
주소
2223 AVENIDA DE LA PLAYA, LA JOLLA
GRI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GRI
Gri Bio Inc
|
1.26 | 3.12M | 0 | -8.26M | -12.17M | -53.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Gri Bio Inc Stock (GRI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-09 | 개시 | H.C. Wainwright | Buy |
Gri Bio Inc 주식(GRI)의 최신 뉴스
GRI Bio (GRI) to Release Quarterly Earnings on Tuesday - Defense World
Combining price and volume data for GRI Bio Inc.Neural Model for Stock Price Movement - Newser
Combining machine learning predictions for GRI Bio Inc.Free Exit Ready Momentum Stock Watchlist - Newser
Full technical analysis of GRI Bio Inc. stockRisk Aware Trading Ideas with Alert Levels - Newser
GRI Bio Reports Promising Early Biomarker Data in Ongoing Study of GRI-0621 for IPF - Managed Healthcare Executive
Strategies to average down on OXLCFree Buy Low Sell High Stock Watch - Newser
GRI Bio Inc. stock trend forecastTechnical Setup Guide for Daily Watchlist - Newser
Is it time to cut losses on JTAIFree High Return Stock Focus With Safety - Newser
Does GRI Bio Inc. show high probability of reboundHigh Yield Watchlist with Filtered Picks - Newser
Regression analysis insights on GRI Bio Inc. performanceFree Daily Chart Pattern Stock Forecast - Newser
Using R and stats models for GRI Bio Inc. forecastingAI Model Forecasting Reversal and Breakout Zones - Newser
Is a relief rally coming for GRI Bio Inc. holdersFree Oversold Bounce Stock Play Ideas - Newser
What are GRI Bio Inc. company’s key revenue driversTriple-digit profit margins - Jammu Links News
How strong is GRI Bio Inc. company’s balance sheetExplosive earnings growth - Jammu Links News
What markets is GRI Bio Inc. expanding into Is CADE stock a good long term investment option - Jammu Links News
Should I hold or sell GRI Bio Inc. stock in 2025Discover high-impact stocks for your portfolio - Jammu Links News
What institutional investors are buying GRI Bio Inc. stockHigh-octane financial growth - Jammu Links News
Does GRI Bio Inc. stock perform well during market downturnsBreakneck growth rates - Jammu Links News
What analysts say about GRI Bio Inc. stockHigh-octane gains - Jammu Links News
What is GRI Bio Inc. company’s growth strategyMaximize gains with professional stock picks - Jammu Links News
Is it the right time to buy GRI Bio Inc. stockUnstoppable trading performance - Jammu Links News
How volatile is GRI Bio Inc. stock compared to the marketAchieve consistent profits with proven strategies - Jammu Links News
What catalysts could drive GRI Bio Inc. stock higher in 2025Unprecedented growth rates - Jammu Links News
Why GRI Bio Inc. stock attracts strong analyst attentionAI Pattern Recognition and Trade Prediction - Newser
What is the dividend policy of GRI Bio Inc. stockLow Risk Forecasts For Smart Trading - Jammu Links News
Why Is Nano Cap GRI Bio Stock Skyrocketing On Tuesday? - 富途牛牛
GRI Bio Reports 6-Week Interim Biomarker Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”) - GlobeNewswire
GRI Bio Plunges 37.62%—What’s Fueling This Sharp Drop in a Biotech Breakthrough? - AInvest
GRI Bio Inc (GRI) Stock: A Comprehensive 52-Week Review - investchronicle.com
GRI Bio CEO, Marc Hertz, Participates in Virtual Investor 'What This Means” Segment - The Manila Times
GRI Bio CEO, Marc Hertz, Participates in Virtual Investor “What This Means” Segment - GlobeNewswire
XPO Reports Q2 2025 Earnings: Adjusted EPS of $1.05, Revenue of $2.08 Billion - AInvest
GRI Bio CEO, Marc Hertz, Participates in Virtual Investor “What This Means” Segment - GlobeNewswire Inc.
GRI Bio Announces Pricing of $5.0 Million Public Offering - ADVFN Brasil
GRI Bio Reports Encouraging Interim 2-Week Safety Results from Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis ('IPF') - ADVFN Brasil
GRI Bio Announces Closing of $5.0 Million Public Offering - ADVFN Brasil
Nasdaq Surges Over 1%; Microsoft Posts Upbeat Earnings - Benzinga
GRI Bio reports positive interim biomarker results in IPF treatment study - Investing.com Nigeria
GRI Bio Announces Positive Interim Data for GRI-0621 - TipRanks
GRI Bio reports positive interim biomarker results in IPF treatment study By Investing.com - Investing.com South Africa
GRI Bio's IPF Drug Shows Promising Biomarker Results in Phase 2a Trial: Safety Confirmed - Stock Titan
Humana Lowers 2025 GAAP EPS Guidance - The Globe and Mail
Published on: 2025-07-31 04:48:46 - Newser
Exit strategy if you’re trapped in GRI Bio Inc.Daily Stock Movement Forecast with Accuracy - Newser
Tariff Shocks and Trade Swings: The Real Drivers of U.S. Growth - The Globe and Mail
Global Value: 3 Stocks Under $10 Riding a Weak Dollar - The Globe and Mail
Gri Bio Inc (GRI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):